Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 3
2019 5
2020 9
2021 10
2022 13
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Talbot A, Bobin A, Tabone L, Lambert J, Boccaccio C, Deal C, Petillon MO, Allangba O, Agape P, Arnautou P, Belkhir R, Cailleres S, Chaoui D, Chrétien ML, Decaux O, Schulmann S, Frenzel L, Gastaud L, Huart A, Hulin C, Karlin L, Laribi K, Le Calloch R, Lenain P, Macro M, Manier S, Montes L, Moreau S, Moreau P, Morel V, Norwood J, Piocelle FO, Perrot A, Pica GM, Rey P, Schmitt A, Stoppa AM, Tiab M, Touzeau C, Vidal V, Vignon M, Vincent L, Van De Wyngaert Z, Zarnitsky C, Kerbouche N, Paka P, Leleu X, Arnulf B, Avet-Loiseau H, Du Myélome IIF. Talbot A, et al. Among authors: van de wyngaert z. Haematologica. 2023 Oct 1;108(10):2774-2782. doi: 10.3324/haematol.2022.281772. Haematologica. 2023. PMID: 37078253 Free PMC article.
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma.
Jovanović KK, Escure G, Demonchy J, Willaume A, Van de Wyngaert Z, Farhat M, Chauvet P, Facon T, Quesnel B, Manier S. Jovanović KK, et al. Among authors: van de wyngaert z. Front Oncol. 2019 Jan 9;8:665. doi: 10.3389/fonc.2018.00665. eCollection 2018. Front Oncol. 2019. PMID: 30687640 Free PMC article. Review.
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Duléry R, Malard F, Brissot E, Banet A, Sestili S, Belhocine R, Calabro M, Van de Wyngaert Z, Bonnin A, Ledraa T, Legrand O, Labopin M, Capderou E, Cohen A, Ederhy S, Mohty M. Duléry R, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Nov;58(11):1215-1222. doi: 10.1038/s41409-023-02085-2. Epub 2023 Aug 18. Bone Marrow Transplant. 2023. PMID: 37596473
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Duléry R, Goudet C, Mannina D, Bianchessi A, Granata A, Harbi S, Maisano V, Chabannon C, Malard F, Brissot E, Sestili S, Banet A, Van de Wyngaert Z, Belhocine R, Ederhy S, Castagna L, Bramanti S, Blaise D, Mohty M, Fürst S, Devillier R. Duléry R, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Apr;58(4):386-392. doi: 10.1038/s41409-022-01908-y. Epub 2022 Dec 30. Bone Marrow Transplant. 2023. PMID: 36585459
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Banet A, Bazarbachi A, Labopin M, Stocker N, Duléry R, Malard F, Van de Wyngaert Z, Genthon A, Memoli M, Legrand O, Bonnin A, Ledraa T, Belhocine R, Sestili S, El-Cheikh J, Mohty M, Brissot E. Banet A, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Jan;58(1):61-67. doi: 10.1038/s41409-022-01841-0. Epub 2022 Oct 12. Bone Marrow Transplant. 2023. PMID: 36224494
COVID-19 outcomes in patients with hematologic disease.
Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, Banet A, Lapusan S, Sestilli S, Corre E, Paviglianiti A, Adaeva R, M 'Hammedi-Bouzina F, Labopin M, Legrand O, Dulery R, Mohty M. Malard F, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2020 Nov;55(11):2180-2184. doi: 10.1038/s41409-020-0931-4. Epub 2020 May 6. Bone Marrow Transplant. 2020. PMID: 32376969 Free PMC article. No abstract available.
Response to pneumococcal vaccination in multiple myeloma.
Renaud L, Schraen S, Fouquet G, Guidez S, Demarquette H, Nudel M, Cayssials E, Bories C, Herbaux C, Systchenko T, Faucompré JL, Machet A, Sabirou F, Levy A, Bobin A, Richez V, Moya N, Gruchet C, Desmier D, van de Wyngaert Z, Carpentier B, Manier S, Facon T, Harding S, Leleu X. Renaud L, et al. Among authors: van de wyngaert z. Cancer Med. 2019 Jul;8(8):3822-3830. doi: 10.1002/cam4.2253. Epub 2019 May 30. Cancer Med. 2019. PMID: 31145552 Free PMC article.
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases.
Otiniano A, van de Wyngaert Z, Brissot E, Dulery R, Gozlan J, Daguenel A, Abi Aad Y, Ricard L, Stocker N, Banet A, Bonnin A, Alsuliman T, Marjanovic Z, Schnuriger A, Coppo P, Legrand O, Lacombe K, Mohty M, Malard F. Otiniano A, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Mar;58(3):340-342. doi: 10.1038/s41409-022-01894-1. Epub 2022 Dec 8. Bone Marrow Transplant. 2023. PMID: 36481838 Free PMC article. No abstract available.
Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma.
Malard F, Battipaglia G, Gaugler B, Siblany L, van de Wyngaert Z, Bonnin A, Duléry R, Banet A, Stocker N, Ricard L, Brissot E, Mohty M. Malard F, et al. Among authors: van de wyngaert z. Bone Marrow Transplant. 2023 Nov;58(11):1275-1278. doi: 10.1038/s41409-023-02078-1. Epub 2023 Aug 22. Bone Marrow Transplant. 2023. PMID: 37608072 No abstract available.
38 results